Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Clinical trial NCT00712426 · TERMINATED
Trial details
- NCT number
- NCT00712426
- Sponsor
- Massachusetts General Hospital
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2014-12-01
- Enrollment
- 553
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.